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During the replication cycle of hepatitis delta virus (HDV), RNA editing occurs at position 1012 on the
1679-nucleotide RNA genome. This changes an A to G in the amber termination codon, UAG, of the small form
of the delta antigen (dAg). The resultant UGG codon, tryptophan, allows the translation of a larger form of the
dAg with a 19-amino-acid C-terminal extension. Using HDV cDNA-transfected cells, we examined the editing
potential of HDV RNA mutated from G to A at 1011 on the antigenome, adjacent to normal editing site at 1012.
Four procedures were used to study not only the editing of the A at 1012, but also that of the new A at 1011:
(i) nucleotide sequencing, (ii) a PCR-based RNA-editing assay, (iii) immunoblot assays, and (iv) immunoflu-
orescence. Five findings are reported. (i) Even after the mutation at 1011, editing still occurred at 1012. (ii) Site
1011 itself now acted as a novel RNA-editing site. (iii) Sites 1011 and 1012 were edited independently. (iv) At
later times, both sites became edited, thereby allowing the synthesis of the large form of the dAg (dAg-L). (v)
Via immunofluorescence, such double editing became apparent as a stochastic event, in that groups of cells
arose in which the changes had taken place. Evaluation of these findings and of those from previous studies
of the stability of the HDV genomic sequence (H. J. Netter et al., J. Virol. 69:1687–1692, 1995) supports both
the recent reevaluation of HDV RNA editing as occurring on antigenomic RNA (Casey and Gerin, personal
communication) and the interpretation that editing occurs via the RNA-modifying enzyme known as DRADA.
RNA editing of hepatitis delta virus (HDV) RNA is essen-
tial during viral infection to create an open reading frame for
one of the two proteins that are essential for virus replication
(4, 20, 28). In particular, editing allows the translation of a
second form of the delta antigen (dAg), the only protein en-
coded by HDV (27). This larger form, dAg-L, has an additional
19 amino acids (aa) at the C terminus (Fig. 1B) relative to the
small form, dAg-S (Fig. 1A). While the original dAg-S is es-
sential for genome replication (15), dAg-L is also biologically
relevant, in that it is needed for virus assembly (7, 24). dAg-L
is isoprenylated at a unique cysteine 4 aa in from the novel
C-terminus region (Fig. 1B) (11). If dAg-L is mutated so that
isoprenylation cannot occur, dAg-L will not function in the
assembly of virion particles (19). It has been demonstrated that
dAg-L is also a dominant negative inhibitor of genome repli-
cation as supported by dAg-S (8), but it is not established wheth-
er such inhibition is an essential part of the virus life cycle.
An RNA-editing site is unquestionably located at position
1012, but there may be other editing positions as well (22). The
immediate target for the editing at position 1012 has been
reported to be the genomic strand (3, 28), although more
recent studies argue, to the contrary, that the target is the anti-
enome (2). The mechanism of HDV RNA editing remains
unclear. As will be explained, it could be carried out by the
recently cloned RNA-modifying enzyme known as DRADA
(14), which seems to be involved in the editing of the genomes
of other RNA viruses (5) and also of certain cellular RNAs (6).
The following studies actually began out of an attempt to
design a mutated HDV that could not make dAg-L even after
the normal RNA-editing event at 1012. With this in mind, the
G at 1011 on the antigenome was changed to A (Fig. 1C).
Thus, editing at 1012 would not only replace the ochre termi-
nation codon, UAA, with an opal terminator, UGA. As doc-
umented here, we found that 1012 was still edited, and to our
surprise, 1011 now became a new and independent editing site.
Some HDV RNAs were even edited at both 1011 and 1012,
thereby replacing the ochre terminator with tryptophan, UGG,
and allowing synthesis of dAg-L (Fig. 1D).
For most of the studies reported here, we actually used not
the single mutant (Fig. 1C) but a double mutant (Fig. 1E) with
an additional mutation, a nearby deletion at position 979. This
deletion was used as a nucleotide sequencing marker. For this
double mutant, even if the dAg-L reading frame were opened
by editing at 1011 and 1012, the 8 aa at the normal C terminus
would be replaced by 9 aa in another reading frame, to pro-
duce a modified form of dAg-L, dAg-L9 (Fig. 1F). As reported
here, we did in fact observe sequence changes consistent with
editing at both 1011 and 1012. Therefore, to exclude any pos-
sible effect of this mutated C-terminal extension on editing, we
repeated certain experiments, as indicated, with the single mu-
tant, and the results were not significantly different.
MATERIALS AND METHODS
Plasmids. Plasmid pSVL(D3) was constructed by insertion of a trimer of unit-
length cloned HDV cDNA (wild type) (16) into expression vector pSVL (Pharma-
cia), as described previously (15). A single mutation at nucleotide (nt) 1011 (Fig. 1C)
and a double mutation at nt 1011 and 979 (Fig. 1E), were introduced via synthetic
oligonucleotides. The single mutant was inserted as a partial dimer into the pSVL
vector pDL538 (18). For the double mutant, a dimer of the modified monomer,
permuted at the unique EcoRI site (16), was inserted into the pSVL vector.
Antibodies. Antibody specific for both dAg-S and dAg-L was raised in rabbits
by inoculation of dAg prepared in Escherichia coli. Rabbit antibody rab-LP3 was
derived against the peptide DILFPADPPFSPQSC, representing the carboxy
terminus of dAg-L (residues 197 to 211) and was shown to recognize dAg-L but
not dAg-S (26). Mouse monoclonal antibody 3G3, recognizing both forms of
dAg, was a generous gift from Michael Lai (13).
Transfection procedure. Huh7 cells (21) were seeded in plastic 35-mm-diam-
eter tissue culture wells (Costar) with or without an inserted 12-mm-diameter
glass coverslip. Lipofectamine (Bethesda Research Laboratories) was used to
transfect subconfluent cells in the presence of Opti-MEM (Bethesda Research
Laboratories), as recommended by the manufacturer (12). Briefly, 12 ml of
Lipofectamine at 2 mg/ml and 2 mg of plasmid DNA were each diluted into 0.5
ml of Opti-MEM. These two dilutions were combined, incubated for 30 min at
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room temperature, and applied to cells that had been washed once with Opti-
MEM. After 5 h of incubation at 378C, the transfection mixture was removed and
the cells were grown in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal calf serum.
RNA extraction and Northern (RNA) analysis. As previously described (9),
total RNA was extracted from transfected cells and, after glyoxalation, was
submitted to electrophoresis in 1.5% agarose gels, followed by RNA blotting to
detect genomic HDV RNA sequences. Genomic full-length HDV RNA probe
was synthesized in vitro in the presence of [a-32P]UTP and used as previously
described (9). Quantitation and image processing were achieved with a Fuji
imager (Fujix BAS1000).
Reverse transcription. For reverse transcription, we used a primer that bound
to genomic RNA (nt 1301 to 1267, according to the nucleotide sequence of Kuo
et al. (16). The RNA template (0.3 mg) was copied, by using avian myeloblastosis
virus reverse transcriptase (Life Sciences, St. Petersburg, Fla.), for 1.5 h at 428C.
The product was incubated with RNase A (160 mg/ml, 20 min, 378C) and then
treated with pronase and sodium dodecyl sulfate, followed by extraction with
phenol and then twice with ether, followed by precipitation with ethanol.
PCR and cDNA sequencing. The product of reverse transcription was sub-
jected to PCR amplification with Taq polymerase and a Techne dry-block ther-
mal cycler (20). The primers spanned nt 1217 to 1183 and 701 to 735 (16), and the
reaction was carried out with 37 cycles of amplification. The PCR products were
then gel purified and cloned with a pGEM-T vector system (Promega). The positive
colonies were selected by a blue-white screening system and Perfectprep plasmid
DNA kit (5 Prime 3 Prime) was used for preparation of plasmid DNA. The DNA
sequence was determined by automatic sequencing (Applied Biosystems).
PCR and editing assay. As described elsewhere (10), the product of reverse
transcription was subjected to nested PCR amplification with Vent polymerase
(New England Biolabs) and an Idaho Technology thermal cycler. One of the final
pair of primers was labeled at the 59 end with biotin so that the product could
be bound to superparamagnetic beads, denatured, and reconverted to double-
stranded DNA with reverse transcriptase and a primer 59 labeled with 32P. The pro-
duct released from the beads by digestion with SalI was tested for susceptibility to
further digestion with NcoI and NlaIII. As shown in Table 2, susceptibility to
these enzymes was specific for editing at positions 1011 and/or 1012 on the HDV
genome. The digestions were assayed by electrophoresis of the products into an
acrylamide gel followed by quantitation of radioactivity with a Fuji imager.
Immunoblot analysis. Transfected cells were lysed, and protein samples were
subjected to electrophoresis in 15% polyacrylamide gels by the method of Lae-
mmli (17). After electrotransfer of proteins to a nitrocellulose filter, dAgs were
detected by using rabbit anti-d antibodies and 125I-labeled protein A (DuPont).
Quantitation and image processing were achieved with a Fuji imager.
Immunofluorescence. Monolayer cultures on glass coverslips were fixed and
stained, as previously described (1). Triple staining of cells was achieved by using
a mixture of mouse monoclonal anti-d antibody 3G3 and rabbit anti-peptide
antibody rab-LP3, specific for dAg-L, as primary antibodies and by addition of 2
mg of 49,6-diamidino-2-phenylindole (DAPI [Sigma]) per ml to stain the cellular
DNA. Goat anti-rabbit immunoglobulin G polyclonal antibody conjugated with
rhodamine (Boehringer) and goat anti-mouse immunoglobulin G plus immuno-
globulin M conjugated with fluorescein (Sigma) were used as secondary anti-
bodies. After being mounted, the samples were viewed with a Zeiss Axiophot
microscope with a 340 objective and specific filter blocks.
RESULTS
Replication of the mutant HDV genome. As presented in the
introduction, the following studies involved examining the con-
sequences for RNA editing at position 1012 on HDV of alter-
ing the adjacent nucleotide at 1011. We compared the wild-
type genome (Fig. 1A) with what we call the single mutant,
which was modified at 1011 (Fig. 1C), or the double mutant,
which was both modified at 1011 and deleted at 979 (Fig. 1E).
At the outset, it was necessary to determine the effect of the
mutations on the ability of the genome to replicate. Figure 2A
shows a detailed comparison of replication for the double
mutant relative to the wild type. Cultures of Huh7 cells were
transfected with either wild-type or double mutant HDV
cDNAs, and at regular intervals thereafter, RNA was extracted
and examined by Northern analysis for HDV genomic RNA
sequences (Fig. 2A). Quantitation of these data (Fig. 2B) in-
dicated that replication of the wild type reached a maximum at
9 days after transfection and then progressively declined. The
extent of replication of the double mutant was as good as or
better than that of the wild type. Similar results were obtained
with the single mutant (data not shown).
Nucleotide sequence analysis. We next used reverse tran-
scription-PCR, cloning, and sequencing to determine the ac-
tual sequence changes that occurred during replication of both
the wild type and the double mutant. We used HDV RNAs
extracted from cells at various times after transfection. In par-
ticular, we studied region 1016 to 945 of the antigenome, as
indicated in Fig. 1.
A total of 92 clones were sequenced, with results as summa-
rized in Table 1. Table 1 shows that for the wild type, the only
changes detected were at position 1012. Consistent with nor-
FIG. 1. Changes on antigenomic HDV RNA as a result of mutagenesis and
editing. Shown are the nucleotide and derived amino acid sequences for the
39-terminal region (nt 1016 to 945) of the open reading frames on antigenomic
HDV RNAs. (A and B) Wild type before and after editing at 1012. (C and D)
Single mutant at 1011 before and after editing at both 1011 and 1012. (E and F)
Double mutant, changed at 1011 and deleted at 979, both before and after
editing at 1011 and 1012. In panel F, the deletion at nt 979 creates a frameshift
and hence an altered amino acid sequence relative to panels B and D.
FIG. 2. Northern analysis of genomic HDV RNA in transfected cells. Cells
were transfected with wild-type HDV cDNA (lanes 1 to 6), mock transfected
(lane 7), or transfected with mutated HDV cDNA (lanes 8 to 13). Samples were
taken at days 3 (lanes 1 and 8), 6 (lanes 2 and 9), 9 (lanes 3 and 10), 12 (lanes
4 and 11), 15 (lanes 5 and 12), and 18 (lanes 6 and 13) after transfection and were
subjected to Northern analysis. (A) Radioactivity as detected with a Fuji imager.
The mobility of the 1.7-kb genomic RNA is indicated at the right side. (B)
Summary of the quantitation of the HDV RNA in transfected cells, expressed in
arbitrary units per constant number of cells. Superimposed are the data for the
wild-type (squares) and mutated (circles) HDV genomes.
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mal HDV editing, these changes were of A3G on the antige-
nome, and the frequency of changes increased with time after
transfection. The wild-type sequences progressively thus changed
from the amber termination codon to the tryptophan codon,
thereby allowing the synthesis of dAg-L.
However, for the double mutant, as summarized in Table 1,
we detected not only changes at 1012 but also changes at 1011.
These latter changes corresponded to A3G on the anti-
genome. Therefore, such changes occurred as if we had cre-
ated a second site of editing adjacent to the normal one. It is
important to note that at the early times, by this sequencing
assay, we only detected changes at either location but not at
both; that is, the two sites were independently susceptible to
the nucleotide change. The initial sequence was the ochre
termination codon, UAA. With time, some sequences changed
A to G at 1012 or 1011, to create the opal or amber terminator,
respectively. Later, by 35 days, we even found that 30% of the
sequences were changed at both locations, so as to create the
tryptophan codon, thereby allowing the synthesis of the mod-
ified form of dAg-L, as predicted in Fig. 1F.
RNA-editing assay. A limitation of the nucleotide sequenc-
ing method described above was sensitivity; for example, to
detect nucleotide changes less frequent than 10%, it would be
necessary to sequence much more than 10 clones. To solve this
problem, we made use of a more sensitive editing assay (10).
PCR amplification of RNAs edited at 1011 and/or 1012 can be
detected via the creation of sites for the restriction enzymes
NcoI and NlaIII. As summarized in Table 2, we readily de-
tected editing at 1012 on the wild-type genome. For the double
mutant, it was now possible to detect single and double editing
as early as days 9 and 18. While these assays were more sen-
sitive than those obtained by the sequencing, for the double
mutant they were unable to distinguish between unedited
UAA and singly edited UAG. Overall, the results of the two
methods were either complementary or in agreement. The
biggest discrepancy between the two methods was at day 9 for
the double mutant being converted to UGA; sequencing of 11
clones indicated 18% (Table 1), while the value deduced by the
subtraction of two sets of restriction enzyme data was 1%
(Table 2). Our interpretation is that this apparent discrepancy
is consistent with the experimental errors of the two methods.
Immunoblot analysis of dAg. We next used immunoblot
analysis in order to detect and quantitate the forms of dAg
synthesized in the transfected cells. For transfections with the
wild type (Fig. 3, lanes 1 to 6) we detected both dAg-S and
dAg-L. As expected, the amount of dAg-L increased with time
and became equal to that of dAg-S at day 18.
For the transfections with the double mutant (lanes 8 to 13),
we also detected dAg-S, but in addition, there was a species
with the mobility of dAg-L. On the basis of the initial sequence
(Fig. 1E), the nucleotide sequencing data (Table 1), and the
RNA-editing assays (Table 2), we made the preliminary inter-
pretation that this band was dAg-L9, just as predicted in Fig.
1F. Consistent with this interpretation, this band and dAg-L,
but not dAg-S, were detected with antibody rab-LP3, a poly-
clonal antibody specific for a peptide sequence unique to the
C-terminal extension of dAg-L but also partially present in the
predicted extension of the putative protein dAg-L9 (data not
shown).
The kinetics of appearance of these dAg species for the
transfections with the wild type and double mutant are shown
in Fig. 3B and C, respectively. The levels of dAg-S showed an
initial increase for 9 days, followed by a decline. Such results
were very similar to those observed for the levels of RNA
replication (Fig. 2B). The differences arise in terms of dAg-L
TABLE 1. Sequence changes during HDV replication, as detected by nucleotide sequencinga
Sequence of antigenome at nt 1013–1011b
% of molecules with this sequence at given no. of days posttransfectionc
9 18 35
Wild type
UAG 5 amber terminator 5 parent 90 (9/10) 50 (5/10) 64 (7/11)
UGG 5 tryptophan 5 1012(A3G) 10 (1/10) 50 (5/10) 36 (4/11)
Double mutant
UAA 5 ochre terminator 5 mutated parent 64 (7/11) 75 (15/20) 3 (1/30)
UAG 5 amber terminator 5 1011(A3G) 5 wild type 18 (2/11) 10 (2/20) 30 (9/30)
UGA 5 opal terminator 5 1012(A3G) 18 (2/11) 15 (3/20) 37 (11/30)
UGG 5 tryptophan 5 1011(A3G) 1 1012(A3G) ,9 (0/11) ,5 (0/20) 30 (9/30)
a Cells were transfected as described in the legend to Fig. 2 with either the wild-type or double-mutant genome. At the indicated times after transfection, RNA-PCR,
cloning, and sequencing of individual clones were performed.
b The table shows only sequences for antigenomic sequence 1013 to 1011, the position of the normal termination codon for dAg. Changes in other regions, with the
exception of nt 979 on the double mutant, were not detected.
c Shown is the percentage of RNA molecules with the indicated sequence. In parentheses is the number of clones of this sequence/total number of clones examined.
TABLE 2. Sequence changes during the HDV replication,
as detected by editing assaysa
Sequence of antigenome at 1013–1011
% of molecules with
this sequence at




UAG 5 amber terminator 5 parent 79 42 58
UGG 5 tryptophan 5 1012(A3G) 21 58 42
Double mutant
UAA 5 ochre terminator 5 mutated
parent and UAG 5 amber terminator
5 1011(A3G) 5 wild-type
96 71 30
UGA 5 opal terminator 5 1012(A3G) 1 14 47
UGG 5 tryptophan 5 1011(A3G) 1
1012(A3G)
3 5 23
a Cells were transfected as for Fig. 2 and Table 1, with either the wild-type or
double-mutant genome.
b At the indicated times posttransfection, RNA-PCR, followed by two editing
assays, was used to determine the fraction of RNA molecules with a given
sequence. The first assay was to determine the percentage of molecules with a
newly created NcoI site (CCATGG), consistent with UGG at 1011 to 1013. For
the double mutant, the second assay was for an NlaIII site (NCATGN), consis-
tent with both UGA and UGG. Thus, subtraction of the result of the first assay
(%UGG) from that of the second (%UGA 1 UGG) yields %UGA. Also,
subtraction of the result of the second assay from 100% yields %UAA 1 UAG.
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and dAg-L9. These differences can be seen in absolute terms
(Fig. 3B and C) but more clearly in terms of the percentage of
total dAg that is either dAg-L or dAg-L9 (Fig. 3D). For the wild
type, this percentage increased, and by day 15, it reached a
plateau of about 50%. In contrast, for the double mutant, the
percentage progressively increased, but even by day 18 had not
even reached 3%. A comparable value was obtained for the
single mutant (data not shown).
Immunofluorescent detection of dAg. The appearance of
dAg-L and dAg-L9 was further studied by immunofluorescence
of transfected cells. Figure 4 shows the data at 9 days, which
corresponds to the peak of genome replication and dAg-S expres-
sion. It is important to note that at this time, the wild-type and
double-mutant genomes have replicated to approximately the
same extent (Fig. 2B). Coverslips were triple stained: with DAPI
to stain nuclear DNA, with an antibody against dAg to detect
total dAg, and with an antipeptide antibody (rab-LP3) to detect
only large forms of dAg (either dAg-L or dAg-L9).
For transfection with wild-type cDNA (Fig. 4A to C), about
40% of the DAPI-staining cells (Fig. 4A) were positive for both
total dAg (Fig. 4B) and dAg-L (Fig. 4C). Positive cells were
detected as small colonies. In these cells, the distribution of total
antigen was nuclear. More specifically, there was diffuse nucleo-
plasmic staining, along with a variable number of discrete dots.
dAg-L and dAg-L9 showed staining of the same dots, but the
amount of diffuse nucleoplasmic staining was relatively smaller.
Cells transfected with the double-mutant cDNA gave a sim-
ilar staining pattern, with one important exception. Only a
fraction, about 30%, of the cells in a clone that were positive
for total antigen (Fig. 4E) were also positive for the large form
(Fig. 4F). This observation was made under conditions in
which the sensitivity of the assay for the large form was in-
creased relative to that for the total—that is, when the positive
signals in panel F were stronger than those in panel E. It
appears, therefore, that only in a subpopulation of mutant-
transfected cells do the mutations occur that are needed to
produce dAg-L9. From an examination of other colonies of
positive cells, the same heterogeneity was found to be the
predominant situation. Less abundant were two other types of
HDV-positive colonies. The first, was one in which each cell
was positive for both total antigen and for the large form. The
second, was one in which none of the cells that were positive
for total antigen were positive for the large form. Since nuclear
dots were detected in these cells by using antibody to total
antigen, it means that the large form was not necessary for
accumulation of antigen into such dots.
The data presented above were collected on day 9. At earlier
times, the large forms were more difficult to detect, especially
for the single and double mutants. With the wild type, the large
form was detectable by day 3, while with the mutants, detection
was first possible at day 6. Even though immunofluorescence
lacks quantitation, the method can have a greater sensitivity
relative to an immunoblot; the large dAgs were detected 3 days
earlier with immunofluorescence than with an immunoblot. At
day 9, there was no detectable difference between the double
mutant and the single mutant (data not shown).
FIG. 3. Immunoblot analysis to detect dAgs in transfected cells. Cells were
transfected exactly as described for Fig. 2. Samples were subjected to immuno-
blot analysis, and are indicated as in Fig. 2. (A) Radioactivity as detected with a
Fuji imager. The mobility of the dAg-S (S) and dAg-L (L, L9) forms of the dAg
are indicated on the right. (B and C) Summary of quantitation, in arbitrary units
per constant number of cells, of total dAg (open symbols), dAg-S (shaded
symbols), and dAg-L and dAg-L9 forms (solid symbols). (B and C) Transfections
with wild-type (squares) and mutated (circles) HDV genomes, respectively. (D)
Fraction (percentage) of the large forms (dAg-L and dAg-L9) relative to the total
dAg. Data are superimposed for transfections with wild-type (squares) and mu-
tated (circles) HDV genomes.
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DISCUSSION
The present study was begun as an attempt to interfere with
the consequences of HDV RNA editing at position 1012. We
made a base change of G-A on the antigenome at the adjacent
nucleotide, 1011. The expectation was that editing at 1012, even if
it occurred on such a mutated genome, would still not allow the
synthesis of the large form of the dAg (Fig. 1C). We found that
the mutated genome not only replicated as well as the wild type
(Fig. 2), but it revealed the following important new information
about HDV editing. (i) Editing of A3G still occurred at 1012
(Tables 1 and 2). (ii) The novel A at 1011 was also changed to G,
as if it became a new target for editing. (iii) Editing occurred
independently at both 1011 and 1012. (iv) At later times after
transfection, molecules edited at both sites were detected. Con-
sistent with this double editing, we detected by immunoblotting
the appearance of species of dAg elongated at the C terminus
(Fig. 3), just as predicted from the mutant sequence (Fig. 1D and
F). (v) Finally, by immunofluorescence for this C-terminal exten-
sion, we detected novel species in transfected cells (Fig. 4). It was
as if cells transfected with the initial sequence were going through
cell divisions and progressively accumulating replication-compe-
tent HDV genomes that were doubly edited.
Our study has to be compared with a previous report by
Casey et al. who studied the effects of a number of single-base
mutations on the ability of HDV RNA to undergo editing at
position 1012 (3). One such mutant was identical to the single
mutant studied here (Fig. 1C). At 13 days after cDNA trans-
fection, they examined the dAg species by immunoblotting and
used an RNA-editing assay to detect changes at 1012. They did
not detect the large dAg-L; this is not surprising in that we found
the amount of dAg-L to be,2% relative to dAg-S (Fig. 3B). Also,
they usedNlaIII to detect editing at 1012 and concluded the level
was,30% of that achieved for the wild type. Our data agree with
this in that we detected 4% and 19% editing at days 9 and 18,
respectively (Table 2). However, our results differ in two impor-
tant ways. First, when we assayed editing at even longer times,
35 days, the editing was as much as 70%. Second, we found that
the mutated 1011 created a new site for editing.
For some time it has been known that during replication of
HDV RNA, the change, referred to as RNA editing, takes
place at position 1012. Casey et al. from an analysis of many
replication-competent genomes, subjected to prior single-base
mutations at and around the editing site, concluded that the
substrate for editing was the genomic RNA (3). Zheng et al.
subsequently came to the same conclusion by a different ap-
proach; they studied editing on nonreplicating HDV RNAs as
expressed in cells and also as incubated in various nuclear
extracts (28). It has not been possible to reproduce the results
of Zheng et al. (data not shown), and furthermore, Casey and
Gerin have more recently obtained better evidence to support
the interpretation that editing occurs on the antigenomic RNA
(2). That is, the change is equivalent to an A-G. Their new data
have reopened the possibility (20) that HDV is edited post-
transcriptionally by a recently cloned RNA-modifying activity,
currently named DRADA, for double-stranded RNA-acti-
vated adenosine deaminase (14). DRADA is a nuclear activity
FIG. 4. Immunofluorescent detection of dAgs in transfected cells. At 9 days after transfection with wild-type (A to C) or mutated (D to F) HDV cDNA, coverslip
cultures were assayed for DAPI staining (A and D), total d proteins (B and E), and dAg-L and dAg-L9 (panels C and F). The scale is indicated in panel F. Panels A
to C are assays of one field of cells; panels D to F are of another. Images were digitized with a Umax scanner and processed with Adobe Photoshop software.
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present in all animal cells (25). It acts on regions of complete
or partial double-stranded RNA (6) and can convert adenosine
to inosine (5). It is known to act on certain cellular RNAs and
even viral RNAs (5, 6). In the case of a replicating RNA like
HDV, this could explain the observed replacement of A-G. As
represented in Fig. 5, the antigenome of wild-type HDV at and
around the adenosine at 1012 can be predicted to fold into a
region with some base pairing. Recently, Polson and Bass have
reported in vitro studies of the RNA substrate requirements
for optimal DRADA activity (23). They have examined not only
the extent of base pairing but also the importance of nucleotides
adjacent to the edited adenosine. The single striking rule that
emerged concerns the 59 neighbor: the frequency of editing is
highest when this neighbor is A or U, much lower for C, and
lowest for G. If we refer to 59-A or 59-U as satisfying the DRADA
rule, then, as now summarized, the following three changes that
occur on HDVRNA satisfy this rule: (i) the 1012 site of wild-type
HDV, (ii) the 1012 site of HDV mutated at 1011, (iii) the 1011
site of mutated HDV. There are even additional examples. (iv) In
a recent study of the stability of HDV during six consecutive
passages in woodchucks, Netter et al. (22) changes corresponding
to A3G on the antigenome not only at 1012 but also at 1005 and
1007, which were changes of at least comparable frequency. The
latter two sites, which can be seen in Fig. 5, also fit the rule. (In
Fig. 5, the three other A’s, at 1009, 1014, and 1020, do not fit
the rule and were not detected as changing). (v) Finally, Netter
et al. detected a total of 40 single-base changes. Of these, 32
(80%) were consistent with an A3G change on either the ge-
nome or the antigenome, and 24 satisfy the 59-neighbor rule (22).
In summary, the studies reported here for HDV replication in
transfected cells and previous studies of HDV replication in an-
imals are consistent with DRADA being the enzyme responsible
for most of the nucleotide changes on replicating HDV RNA.
Is there competition between the replication of the edited
and the unedited RNAs? Such competition could occur at two
levels. First, it certainly may occur when HDV RNA is assem-
bled into particles; in a subsequent infection of susceptible cells,
genomes changed at 1012 would be unable to synthesize the
dAg-S needed for replication. Second, from the study of Bichko et
al. (1), we now know that even in the absence of assembly, HDV
replication can continue after multiple rounds of cell division.
Thus, at any time, a major feature in determining whether an
HDV RNA species predominates could be replication compe-
tence. Some species, either because of the location or extent of
editing, could be at a disadvantage to other edited RNAs and
could certainly be at a disadvantage relative to the wild type.
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FIG. 5. Predicted rodlike folding of HDV antigenomic sequences at and
around the editing site at 1012. The sequence, predicted base pairing, and
numbering are as described by Kuo et al. (16). Note that the edited A at 1012,
shown in boldface, is predicted to be adjacent to nt 580 on the other side of the
rodlike structure. 1012 is thus not predicted to be base paired. Also, if 1011 is
mutated to A, it is not predicted to be paired.
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